History: Time to re-evaluate the legacy of forgotten germline exposures?
These mothers of children with autism and other neurodevelopmental abnormalities all have one thing in common: circa 1960s in-utero exposures to endocrine-disrupting pharmaceutical drugs, none of which had been tested for molecular impacts on oocytes, which develop while the female is in the womb (a girl is born with all her eggs).
Their stories will be posted soon. We will also publish a page on offspring of males gestationally exposed to these drugs. We appreciate your patience.
Their stories will be posted soon. We will also publish a page on offspring of males gestationally exposed to these drugs. We appreciate your patience.
Jill Escher
Prenatally exposed in 1965 to "antimiscarriage" progestins, corticosteroids, estrogens. Two children with autism, b. 1999 and 2006. |
Diana Snipps: Prenatally exposed to "antimiscarriage" progestins
Coming soon One son with autism. |
Chrissy Young: Prenatally exposed to "antimiscarriage" synthetic hormone drugs
Coming soon One son with conduct disorder. One daughter with learning disabilities. 
Jacqueline Grant: Prenatally exposed to "antimiscarriage" hormone drugs
Coming soon Four children with neurodevelopmental disability: two sons with autism, one son with ADHD, one son with pervasive developmental disorder.
Jenna Heatherton: Prenatally exposed to "antimiscarriage" hormone drugs
Coming soon Three children with autism. |
Vicki Reinhardt: Prenatally exposed to "antimiscarriage" DES (diethylstilbestrol)
Coming soon One son with autism. 
Chellie Scalare: Prenatally exposed to anti-nausea drugs
Coming soon One son with autism.
Linda Ball: Prenatally exposed to "antimiscarriage" progestins
Coming soon One son with autism. |